Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02101424 · ClinicalTrials.gov registry record

Monitoring of Overdose Patients With and Without Supplemental Oxygen in the Emergency Department

A clinical trial of Overdose, sponsored by Hennepin Healthcare Research Institute.

Completed
Registry status
300
Enrollment target
1
Study location

NCT02101424: Completed study of Overdose, sponsored by Hennepin Healthcare Research Institute.

NCT02101424 is a study of Overdose that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 300 participants, above the 243-participant average among 13 other Overdose trials with a reported enrollment target (23% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02101424, a study of Overdose, has completed, sponsored by Hennepin Healthcare Research Institute.

COMPLETED
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

This study will compare the data from pulse oximeters to capnographers as they are used to monitor patients who are being observed in the Emergency Department for a suspected overdose of alcohol or other drugs. The investigators will compare monitor data from patients who are and are not on supplemental oxygen, the ability of the monitors to predict the occurrence of airway interventions, and to detect ventilator changes noted on the opposing monitor. There will not be any interventions during this study other than the collection of data from the monitors and observation of the care of patients.

Primary Outcome

Addition or increase in supplemental oxygen, stimulation to induce respiration, airway repositioning, bag-valve-mask application, positive pressure ventilation, intubation, airway suctioning, vomiting, medication administration, transfer to a higher level of care.

Conditions Studied

Study Locations (1)

Minnesota

  • Hennepin County Medical Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2010-05
Est. Completion 2013-12

What the finished NCT02101424 record still lists

NCT02101424 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 243-participant average among 13 other Overdose trials with a reported enrollment target (23% higher).

The record links to 1 condition, with Overdose appearing as the primary indexed condition, and to 0 interventions.

NCT02101424 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02101424 about?

NCT02101424 is a clinical study titled "Monitoring of Overdose Patients With and Without Supplemental Oxygen in the Emergency Department". This study will compare the data from pulse oximeters to capnographers as they are used to monitor patients who are being observed in the Emergency Department for a suspected overdose of alcohol or other drugs. The investigators will compare monitor data from patients who are and are not on suppleme...

What is the current status of trial NCT02101424?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2010-05. Estimated completion is 2013-12.

What conditions does trial NCT02101424 study?

This clinical trial studies the following conditions: Overdose.

Who is sponsoring clinical trial NCT02101424?

This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02101424 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overdose

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02101424's enrollment target sits among peer trials

300 4th of 13 higher than 9 of 13 other Overdose trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overdose trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02101424, the US trial registry maintained by the National Library of Medicine. NCT02101424 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.